Published in Ann Intern Med on January 07, 2008
Hospitalizations and deaths among adults with cardiovascular disease who underuse medications because of cost: a longitudinal analysis. Med Care (2010) 2.05
The effect of Medicare Part D coverage on drug use and cost sharing among seniors without prior drug benefits. Health Aff (Millwood) (2009) 1.95
Falling into the coverage gap: Part D drug costs and adherence for Medicare Advantage prescription drug plan beneficiaries with diabetes. Health Serv Res (2009) 1.66
Ambulatory antibiotic use and prescription drug coverage in older adults. Arch Intern Med (2010) 1.60
Recent trends in cost-related medication nonadherence among stroke survivors in the United States. Ann Neurol (2013) 1.46
The impact of Medicare Part D on hospitalization rates. Health Serv Res (2011) 1.43
Medicare Part D coverage gap and diabetes beneficiaries. Am J Manag Care (2009) 1.40
Take-up of Medicare Part D: results from the Health and Retirement Study. J Gerontol B Psychol Sci Soc Sci (2009) 1.37
Comparison friction: experimental evidence from medicare drug plans. Q J Econ (2012) 1.33
Prescription drug insurance coverage and patient health outcomes: a systematic review. Am J Public Health (2015) 1.27
How the Medicare Part D drug benefit changed the distribution of out-of-pocket pharmacy spending among older beneficiaries. J Gerontol B Psychol Sci Soc Sci (2009) 1.23
Changes in drug use and out-of-pocket costs associated with Medicare Part D implementation: a systematic review. J Am Geriatr Soc (2010) 1.22
Medicare part D and changes in prescription drug use and cost burden: national estimates for the Medicare population, 2000 to 2007. Med Care (2011) 1.21
Impact of Medicare Part D on Medicare-Medicaid dual-eligible beneficiaries' prescription utilization and expenditures. Health Serv Res (2009) 1.19
Nursing home residents and enrollment in Medicare Part D. J Am Geriatr Soc (2009) 1.14
Universal drug coverage and socioeconomic disparities in major diabetes outcomes. Diabetes Care (2012) 1.14
Prescription coverage, use and spending before and after Part D implementation: a national longitudinal panel study. J Gen Intern Med (2009) 1.12
Impact of Medicare Part D on antidepressant treatment, medication choice, and adherence among older adults with depression. Am J Geriatr Psychiatry (2011) 1.11
The Medicare drug benefit (Part D) and treatment of heart failure in older adults. Am Heart J (2010) 1.10
The impact of the Medicare Part D prescription benefit on generic drug use. J Gen Intern Med (2008) 1.08
Completeness of retail pharmacy claims data: implications for pharmacoepidemiologic studies and pharmacy practice in elderly patients. Clin Ther (2009) 1.05
From the patient perspective: the economic value of seasonal and H1N1 influenza vaccination. Vaccine (2011) 1.05
Medicare Part D and quality of prescription medication use in older adults. Drugs Aging (2011) 1.05
Medicare part D enrollment in a biracial community-based population of older adults. Gerontologist (2009) 1.04
Healthcare reform in the United States and China: pharmaceutical market implications. J Pharm Policy Pract (2014) 1.02
Digesting the doughnut hole. J Health Econ (2013) 1.00
Medicare Part D: a successful start with room for improvement. JAMA (2008) 0.99
Medicare part D after 2 years. Am J Manag Care (2009) 0.99
Cost sharing and decreased branded oral anti-diabetic medication adherence among elderly Part D Medicare beneficiaries. J Gen Intern Med (2013) 0.98
The impact of Medicare Part D on medication treatment of hypertension. Health Serv Res (2010) 0.98
The impact of Medicare Part D on out-of-pocket costs for prescription drugs, medication utilization, health resource utilization, and preference-based health utility. Health Serv Res (2011) 0.98
THE RESPONSE OF DRUG EXPENDITURE TO NON-LINEAR CONTRACT DESIGN: EVIDENCE FROM MEDICARE PART D. Q J Econ (2015) 0.97
Ethnic disparities in adherence to antihypertensive medications of medicare part D beneficiaries. J Am Geriatr Soc (2012) 0.97
How Medicare Part D benefit phases affect adherence with evidence-based medications following acute myocardial infarction. Health Serv Res (2013) 0.93
Market Size and Innovation: Effects of Medicare Part D on Pharmaceutical Research and Development. J Public Econ (2013) 0.87
Factors Associated with Persistence with Teriparatide Therapy: Results from the DANCE Observational Study. J Osteoporos (2011) 0.87
Where are the Medicare Part D claims data? Ann Intern Med (2008) 0.85
Medicare Part D and potentially inappropriate medication use in the elderly. Am J Manag Care (2012) 0.85
Medicare part D's impact on antipsychotic drug use and costs among elderly patients without prior drug insurance. J Clin Psychopharmacol (2012) 0.83
Reconsideration of key articles regarding medication-related problems in older adults from 2011. Am J Geriatr Pharmacother (2012) 0.81
Potential bias in medication adherence studies of prevalent users. Health Serv Res (2013) 0.80
Pharmaceutical advertising and Medicare Part D. J Health Econ (2013) 0.79
Medicare Part D plan generosity and medication use among dual-eligible nursing home residents. Med Care (2013) 0.79
Awareness of pharmaceutical cost-assistance programs among inner-city seniors. Am J Geriatr Pharmacother (2009) 0.79
Pharmacy accessibility and cost-related underuse of prescription medications in low-income Black and Hispanic urban communities. J Am Pharm Assoc (2003) (2017) 0.78
Effects of Medicare Part D on drug affordability and use: Are seniors with prior high out-of-pocket drug spending affected more? Res Social Adm Pharm (2010) 0.78
Drug benefit changes under Medicare Advantage Part D: heterogeneous effects on pharmaceutical use and expenditures. J Gen Intern Med (2011) 0.77
Socioeconomic Disparities in Mortality Among Women With Incident Breast Cancer Before and After Implementation of Medicare Part D. Med Care (2016) 0.75
Insurers' Negotiating Leverage and the External Effects of Medicare Part D. Rev Econ Stat (2015) 0.75
The doughnut hole: it's about medication adherence. Ann Intern Med (2012) 0.75
Impact of Medicare Part D on Racial and Ethnic Minorities. Divers Equal Health Care (2016) 0.75
Caution in generalizing Part D results to Medicare population. Arch Intern Med (2011) 0.75
Patents, innovation, and the welfare effects of Medicare Part D. Adv Health Econ Health Serv Res (2010) 0.75
Risk factors of self-reported adverse drug events among Medicare enrollees before and after Medicare Part D. Pharm Pract (Granada) (2009) 0.75
The impact of health insurance expansion on physician treatment choice: Medicare Part D and physician prescribing. Int J Health Econ Manag (2017) 0.75
Lying to insurance companies: the desire to deceive among physicians and the public. Am J Bioeth (2004) 8.49
Two-stage residual inclusion estimation: addressing endogeneity in health econometric modeling. J Health Econ (2007) 5.61
Use of prescription and over-the-counter medications and dietary supplements among older adults in the United States. JAMA (2008) 5.27
What does the value of modern medicine say about the $50,000 per quality-adjusted life-year decision rule? Med Care (2008) 5.14
Generalized modeling approaches to risk adjustment of skewed outcomes data. J Health Econ (2005) 4.52
Patient-physician communication about out-of-pocket costs. JAMA (2003) 4.47
Reconsidering medication appropriateness for patients late in life. Arch Intern Med (2006) 3.81
Frequency of failure to inform patients of clinically significant outpatient test results. Arch Intern Med (2009) 3.55
Projecting the future diabetes population size and related costs for the U.S. Diabetes Care (2009) 3.34
Knowledge and early adoption of the HPV vaccine among girls and young women: results of a national survey. J Adolesc Health (2009) 3.13
Sleep-disordered breathing and postoperative outcomes after elective surgery: analysis of the nationwide inpatient sample. Chest (2013) 2.78
Why physicians work when sick. Arch Intern Med (2012) 2.65
Hospital readmission in general medicine patients: a prediction model. J Gen Intern Med (2009) 2.63
Association of workload of on-call medical interns with on-call sleep duration, shift duration, and participation in educational activities. JAMA (2008) 2.56
Association of patient preferences for participation in decision making with length of stay and costs among hospitalized patients. JAMA Intern Med (2013) 2.35
Minocycline reduces proinflammatory cytokine expression, microglial activation, and caspase-3 activation in a rodent model of diabetic retinopathy. Diabetes (2005) 2.28
National trends in oral anticoagulant use in the United States, 2007 to 2011. Circ Cardiovasc Qual Outcomes (2012) 2.27
The Food and Drug Administration Amendments Act and postmarketing commitments. JAMA (2013) 2.27
Patient perceptions of quality of life with diabetes-related complications and treatments. Diabetes Care (2007) 2.17
White paper on CTSA consortium role in facilitating comparative effectiveness research: September 23, 2009 CTSA consortium strategic goal committee on comparative effectiveness research. Clin Transl Sci (2010) 2.09
The cost-effectiveness of improving diabetes care in U.S. federally qualified community health centers. Health Serv Res (2007) 2.09
The effect of comorbid illness and functional status on the expected benefits of intensive glucose control in older patients with type 2 diabetes: a decision analysis. Ann Intern Med (2008) 2.08
Multicenter development and validation of a risk stratification tool for ward patients. Am J Respir Crit Care Med (2014) 2.06
Impact of FDA black box advisory on antipsychotic medication use. Arch Intern Med (2010) 2.05
Proinflammatory mediators released by activated microglia induces neuronal death in Japanese encephalitis. Glia (2007) 2.04
National trends in cyclooxygenase-2 inhibitor use since market release: nonselective diffusion of a selectively cost-effective innovation. Arch Intern Med (2005) 2.01
The population value of quality indicator reporting: a framework for prioritizing health care performance measures. Health Aff (Millwood) (2014) 1.98
Are Food and Drug Administration prescription drug safety plans working? A case study of isotretinoin. Pharmacoepidemiol Drug Saf (2013) 1.97
The role of surgeon error in withdrawal of postoperative life support. Ann Surg (2012) 1.97
Derivation of a cardiac arrest prediction model using ward vital signs*. Crit Care Med (2012) 1.96
Physician strategies to reduce patients' out-of-pocket prescription costs. Arch Intern Med (2005) 1.95
The physician-surrogate relationship. Arch Intern Med (2007) 1.93
Primary outcomes for resuscitation science studies: a consensus statement from the American Heart Association. Circulation (2011) 1.93
Impact of FDA drug risk communications on health care utilization and health behaviors: a systematic review. Med Care (2012) 1.91
Substituted judgment: the limitations of autonomy in surrogate decision making. J Gen Intern Med (2008) 1.88
Predictors of hospitalised patients' preferences for physician-directed medical decision-making. J Med Ethics (2011) 1.88
Barriers to patient-physician communication about out-of-pocket costs. J Gen Intern Med (2004) 1.87
The prescription opioid and heroin crisis: a public health approach to an epidemic of addiction. Annu Rev Public Health (2015) 1.86
Estimate of the carbon footprint of the US health care sector. JAMA (2009) 1.86
Japanese encephalitis-a pathological and clinical perspective. PLoS Negl Trop Dis (2009) 1.82
Noise and sleep among adult medical inpatients: far from a quiet night. Arch Intern Med (2012) 1.75
Association of communication between hospital-based physicians and primary care providers with patient outcomes. J Gen Intern Med (2008) 1.72
General internists' views on pay-for-performance and public reporting of quality scores: a national survey. Health Aff (Millwood) (2007) 1.71
Outpatient hypertension treatment, treatment intensification, and control in Western Europe and the United States. Arch Intern Med (2007) 1.69
Promotion of prescription drugs to consumers and providers, 2001-2010. PLoS One (2013) 1.66
Minocycline neuroprotects, reduces microglial activation, inhibits caspase 3 induction, and viral replication following Japanese encephalitis. J Neurochem (2008) 1.65
No time for teaching? Inpatient attending physicians' workload and teaching before and after the implementation of the 2003 duty hours regulations. Acad Med (2013) 1.63
The cost consequences of improving diabetes care: the community health center experience. Jt Comm J Qual Patient Saf (2008) 1.62
Using clinical information to project federal health care spending. Health Aff (Millwood) (2009) 1.62
Out-of-pocket and total costs of fixed-dose combination antihypertensives and their components. Am J Hypertens (2008) 1.60
Multilevel modeling and practice-based research. Ann Fam Med (2005) 1.58
Prioritizing future research on off-label prescribing: results of a quantitative evaluation. Pharmacotherapy (2008) 1.58
Economic implications of nighttime attending intensivist coverage in a medical intensive care unit. Crit Care Med (2011) 1.57
Evaluating resident duty hour reforms: more work to do. JAMA (2007) 1.56
Relationship between quality of care of hospitalized vulnerable elders and postdischarge mortality. J Am Geriatr Soc (2010) 1.56
Health literacy as a predictor of follow-up after an abnormal Pap smear: a prospective study. J Gen Intern Med (2006) 1.55
Inflammation: a new candidate in modulating adult neurogenesis. J Neurosci Res (2008) 1.55
Critical care physicians' approaches to negotiating with surrogate decision makers: a qualitative study. Crit Care Med (2012) 1.54
Surgeons expect patients to buy-in to postoperative life support preoperatively: results of a national survey. Crit Care Med (2013) 1.53
Surgeon-reported conflict with intensivists about postoperative goals of care. JAMA Surg (2013) 1.49
Racial/ethnic differences in concerns about current and future medications among patients with type 2 diabetes. Diabetes Care (2008) 1.49
Characteristics of patients receiving pharmaceutical samples and association between sample receipt and out-of-pocket prescription costs. Med Care (2008) 1.48
Changes in glitazone use among office-based physicians in the U.S., 2003-2009. Diabetes Care (2010) 1.46
Responding to an FDA warning--geographic variation in the use of rosiglitazone. N Engl J Med (2010) 1.46
Synthesis of a novel quinoline derivative, 2-(2-methylquinolin-4-ylamino)-N-phenylacetamide--a potential antileishmanial agent. Bioorg Med Chem (2002) 1.44
The cost-effectiveness of continuous glucose monitoring in type 1 diabetes. Diabetes Care (2010) 1.43
Impact of a drug utilization review program on high-risk use of prescription controlled substances. Pharmacoepidemiol Drug Saf (2013) 1.42
Impact of abuse-deterrent OxyContin on prescription opioid utilization. Pharmacoepidemiol Drug Saf (2014) 1.42
Perspectives on public health workforce research. J Public Health Manag Pract (2009) 1.41
Ambulatory diagnosis and treatment of nonmalignant pain in the United States, 2000-2010. Med Care (2013) 1.40
On-call supervision and resident autonomy: from micromanager to absentee attending. Am J Med (2009) 1.40
Using assessing care of vulnerable elders quality indicators to measure quality of hospital care for vulnerable elders. J Am Geriatr Soc (2007) 1.40
Should editorials in peer-reviewed journals be signed? Chest (2006) 1.40
Recommendations to limit life support: a national survey of critical care physicians. Am J Respir Crit Care Med (2012) 1.39
Prescriptions, nonmedical use, and emergency department visits involving prescription stimulants. J Clin Psychiatry (2016) 1.39
More than meets the eye: relationship between low health literacy and poor vision in hospitalized patients. J Health Commun (2013) 1.38
The impact of patient preferences on the cost-effectiveness of intensive glucose control in older patients with new-onset diabetes. Diabetes Care (2006) 1.38
National trends in ambulatory asthma treatment, 1997-2009. J Gen Intern Med (2011) 1.37
U.S. physician knowledge of the FDA-approved indications and evidence base for commonly prescribed drugs: results of a national survey. Pharmacoepidemiol Drug Saf (2009) 1.34
Understanding communication during hospitalist service changes: a mixed methods study. J Hosp Med (2009) 1.34
The lack of effect of market structure on hospice use. Health Serv Res (2002) 1.33
Ambulatory treatment of type 2 diabetes in the U.S., 1997-2012. Diabetes Care (2013) 1.32
Inflammasome signaling at the heart of central nervous system pathology. J Neurosci Res (2010) 1.28
Problems after discharge and understanding of communication with their primary care physicians among hospitalized seniors: a mixed methods study. J Hosp Med (2010) 1.26
A text messaging intervention to improve heart failure self-management after hospital discharge in a largely African-American population: before-after study. J Med Internet Res (2013) 1.24
Does doctor-patient communication affect patient satisfaction with hospital care? Results of an analysis with a novel instrumental variable. Health Serv Res (2008) 1.23
Elderly patients' preferences and experiences with providers in managing their drug costs. J Am Geriatr Soc (2007) 1.21
A CTSA agenda to advance methods for comparative effectiveness research. Clin Transl Sci (2011) 1.21
Impact of Medicare Part D on Medicare-Medicaid dual-eligible beneficiaries' prescription utilization and expenditures. Health Serv Res (2009) 1.19
Racial and ethnic disparities in cardiovascular medication use among older adults in the United States. Pharmacoepidemiol Drug Saf (2010) 1.19
Influence of language barriers on outcomes of hospital care for general medicine inpatients. J Hosp Med (2010) 1.18
Protective and vulnerability factors predicting new-onset depressive episode in a representative of U.S. adolescents. J Adolesc Health (2008) 1.18
Patient acuity rating: quantifying clinical judgment regarding inpatient stability. J Hosp Med (2011) 1.15
Physicians' experience with surrogate decision making for hospitalized adults. J Gen Intern Med (2009) 1.15
Trends in attention deficit hyperactivity disorder ambulatory diagnosis and medical treatment in the United States, 2000-2010. Acad Pediatr (2012) 1.15